20-34709508-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021202.3(TP53INP2):c.397G>A(p.Gly133Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000995 in 1,608,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021202.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TP53INP2 | NM_021202.3 | c.397G>A | p.Gly133Ser | missense_variant | 4/5 | ENST00000374810.8 | NP_067025.1 | |
TP53INP2 | NM_001329429.2 | c.397G>A | p.Gly133Ser | missense_variant | 4/5 | NP_001316358.1 | ||
TP53INP2 | NM_001329430.2 | c.397G>A | p.Gly133Ser | missense_variant | 3/4 | NP_001316359.1 | ||
TP53INP2 | NM_001329431.2 | c.397G>A | p.Gly133Ser | missense_variant | 4/5 | NP_001316360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP53INP2 | ENST00000374810.8 | c.397G>A | p.Gly133Ser | missense_variant | 4/5 | 1 | NM_021202.3 | ENSP00000363943 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000338 AC: 8AN: 236458Hom.: 0 AF XY: 0.0000384 AC XY: 5AN XY: 130046
GnomAD4 exome AF: 0.000105 AC: 153AN: 1456128Hom.: 0 Cov.: 36 AF XY: 0.000102 AC XY: 74AN XY: 724572
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.397G>A (p.G133S) alteration is located in exon 4 (coding exon 2) of the TP53INP2 gene. This alteration results from a G to A substitution at nucleotide position 397, causing the glycine (G) at amino acid position 133 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at